APA (7th ed.) Citation

Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., . . . Moller, D. E. (2013). The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell metabolism, 18(3), 333. https://doi.org/10.1016/j.cmet.2013.08.005

Chicago Style (17th ed.) Citation

Gaich, Gregory, et al. "The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes." Cell Metabolism 18, no. 3 (2013): 333. https://doi.org/10.1016/j.cmet.2013.08.005.

MLA (9th ed.) Citation

Gaich, Gregory, et al. "The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes." Cell Metabolism, vol. 18, no. 3, 2013, p. 333, https://doi.org/10.1016/j.cmet.2013.08.005.